company background image
506919 logo

Makers Laboratories BSE:506919 Stock Report

Last Price

₹135.05

Market Cap

₹796.8m

7D

7.0%

1Y

24.7%

Updated

17 Apr, 2024

Data

Company Financials

Makers Laboratories Limited

BSE:506919 Stock Report

Market Cap: ₹796.8m

506919 Stock Overview

Makers Laboratories Limited, an integrated pharmaceutical company, manufactures and markets formulations in India.

506919 fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance0/6
Financial Health3/6
Dividends0/6

Makers Laboratories Limited Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Makers Laboratories
Historical stock prices
Current Share Price₹135.05
52 Week High₹157.00
52 Week Low₹94.00
Beta1.31
1 Month Change11.80%
3 Month Change-2.63%
1 Year Change24.72%
3 Year Change-45.62%
5 Year Change141.16%
Change since IPO275.14%

Recent News & Updates

Recent updates

Shareholder Returns

506919IN PharmaceuticalsIN Market
7D7.0%-2.8%-1.5%
1Y24.7%54.9%45.0%

Return vs Industry: 506919 underperformed the Indian Pharmaceuticals industry which returned 54.9% over the past year.

Return vs Market: 506919 underperformed the Indian Market which returned 45% over the past year.

Price Volatility

Is 506919's price volatile compared to industry and market?
506919 volatility
506919 Average Weekly Movement7.4%
Pharmaceuticals Industry Average Movement5.9%
Market Average Movement6.9%
10% most volatile stocks in IN Market10.1%
10% least volatile stocks in IN Market4.2%

Stable Share Price: 506919 has not had significant price volatility in the past 3 months.

Volatility Over Time: 506919's weekly volatility (7%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
1984121Saahil Parikhwww.makerslabs.com

Makers Laboratories Limited, an integrated pharmaceutical company, manufactures and markets formulations in India. It offers products in general health therapeutic area, including acid regulatory, anthelmintic, anti-allergic, anti-asthmatic, anti-biotic, anti-diabetics, anti-diarrhoeals, anti-emetics and anti-nauseants, anti-fungal, anti-hypertensive, anti–inflammatory, analgesic, anti-spasmodic, anti-malarial, anti-thyroid, cough and cold control, digestives, neurotonic, nutritional supplements, topical anti-biotic/anti-microbial, and other specialties. The company offers its products under the Duramol, Artemak-AB, Loroquin, Nimuwin, Coffwin, and Exylin brand names.

Makers Laboratories Limited Fundamentals Summary

How do Makers Laboratories's earnings and revenue compare to its market cap?
506919 fundamental statistics
Market cap₹796.85m
Earnings (TTM)-₹52.60m
Revenue (TTM)₹1.06b

0.8x

P/S Ratio

-15.2x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
506919 income statement (TTM)
Revenue₹1.06b
Cost of Revenue₹552.71m
Gross Profit₹507.57m
Other Expenses₹560.17m
Earnings-₹52.60m

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

n/a

Earnings per share (EPS)-8.91
Gross Margin47.87%
Net Profit Margin-4.96%
Debt/Equity Ratio14.2%

How did 506919 perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.